Patent details

EP1392341 Title: PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA WHICH IS OPTIMISED FOR TRANSLATION IN THE CODING REGIONS THEREOF

Basic Information

Publication number:
EP1392341
PCT Application Number:
PCT/EP/2002/006180
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027327527
PCT Publication Number:
WO/2002/098443
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA WHICH IS OPTIMISED FOR TRANSLATION IN THE CODING REGIONS THEREOF
French Title of Invention:
COMPOSITION PHARMACEUTIQUE CONTENANT UN ARNM STABILISE ET OPTIMISE POUR LA TRADUCTION DANS SES REGIONS CODANTES
German Title of Invention:
STABILISIERTE MRNA MIT ERHÖHTEM G/C-GEHALT UND OPTIMIERTER CODON USAGE FÜR DIE GENTHERAPIE
SPC Number:

Dates

Filing date:
05/06/2002
Grant date:
30/03/2005
EP Publication Date:
30/03/2005
PCT Publication Date:
12/12/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/03/2004
EP B1 Publication Date:
30/03/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/06/2005
Expiration date:
05/06/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/06/2002
 
 

Name:
Curevac GmbH
Address:
Paul-Ehrlich-Str. 15, 72076 Tübingen, Germany (DE)

Inventor

1

Name:
PASCOLO Steve
Address:
Germany (DE)

2

Name:
HOERR Ingmar
Address:
Germany (DE)

3

Name:
VON DER MÜLBE Florian
Address:
Germany (DE)

Priority

Priority Number:
10127283
Priority Date:
05/06/2001
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 38/00;
Filing date Document type Number of pages